Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.
Xin Du, Jiong Hu, Zhu Chen, Sai-Juan Chen, Jun Ma, Xiao-Jun Huang, Kang Yu, Bao-An Chen, Jie Jin, Jian-Xiang Wang, Fei-Fei Chen, De-Pei Wu, Jian-Feng Zhou, Jian-Da Hu, Jian-Min Wang, Jian-Yong Li, Chun-Yan Ji, Xiao-Ping Xu, Han-Yun Ren, Yu-Hong Zhou, Yin Tong, Yin-Jun Lou, Wan-Mao Ni, Hong-Yan Tong, Hua-Feng Wang, Ying-Chang Mi, Yi Shen
The Lancet. Oncology 2013;14(7):599-608